Global Clinical Trial Management System Market

1 INTRODUCTION OF GLOBAL CLINICAL TRIAL MANAGEMENT MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK
4.1 Overview

4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities

4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY TYPE
5.1 Enterprise
5.2 On site

6 THE CLINICAL TRIAL MANAGEMENT MARKET, BY DELIVERY MODE
6.1 Web-Based (Hosted) CTMS
6.2 Licensed Enterprise (On Premise) CTMS
6.3 Cloud-Based (SaaS) CTMS

7 THE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT
7.1 Software
7.2 Services

8 THE CLINICAL TRIAL MANAGEMENT MARKET, BY END USER
8.1 Pharmaceutical and Biopharmaceutical Companies
8.2 Contract Research Organizations
8.3 Medical Device Companies
8.4 Others

9 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY

9.1 Overview

9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico

9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe

9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific

9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

10 GLOBAL CLINICAL TRIAL MANAGEMENT MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Oracle Corporation
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Medidata Solutions, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Parexel International Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Bioclinica, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Bio-Optronics, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Merge Healthcare Incorporated
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Datatrak International, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Veeva Systems, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 DSG Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 Eclinforce, Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 ERT
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments

11.12 Forte Research Systems, Inc.
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

11.13 Mednet Solutions, Inc.
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments

12 Appendix
12.1 Related Reports